Synapse - Martin Klatt

Results (22)

Empirical and rational design of T cell receptor-based immunotherapies

Review

Jones, H. F.; Molvi, Z.; Klatt, M. G.; Dao, T.; Scheinberg, D. A.
Frontiers in Immunology (2021)

A TCR mimic antibody-directed CAR T cell specific for intracellular NDC80 is broadly cancer reactive and displays high activity against hematological malignancies

Meeting Abstract

Klatt, M. G.; Yang, Z.; Liu, J.; Korontsvit, T.; Mun, S. S.; Peraro, L.; Gardner, T. J.; Bourne, C.; Dacek, M. M.; Dao, T.; more...
Blood (2020)

Fulltext@MSK | Save

Solving an MHC allele-specific bias in the reported immunopeptidome

Journal Article

Klatt, M. G.; Mack, K. N.; Bai, Y.; Aretz, Z. E. H.; Nathan, L. I.; Mun, S. S.; Dao, T.; Scheinberg, D. A.
JCI Insight (2020)

Fulltext@MSK | Save

An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments

Journal Article

Klatt, M. G.; Aretz, Z. E. H.; Curcio, M.; Gejman, R. S.; Jones, H. F.; Scheinberg, D. A.
Journal of Proteomics (2020)

Fulltext@MSK | Save

Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform

Journal Article

Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
Cancer Immunology Research (2020)

Fulltext@MSK | Save

T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers

Meeting Abstract

Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
Molecular Cancer Therapeutics (2019)

Fulltext@MSK | Save

ALK and RET inhibitors promote HLA class I antigen presentation and unmask new antigens within the tumor immunopeptidome

Journal Article

Oh, C. Y.; Klatt, M. G.; Bourne, C.; Dao, T.; Dacek, M. M.; Brea, E. J.; Mun, S. S.; Chang, A. Y.; Korontsvit, T.; Scheinberg, D. A.
Cancer Immunology Research (2019)

Fulltext@MSK | Save

T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers

Meeting Abstract

Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Identification of neoantigens from non-primary tumor tissue in patients with recurrent ovarian cancer by sequencing and subsequent HLA ligand mass spectrometry